Boehringer Ingelheim Recalls Catapres Tablets Due to Dissolution Failures
Boehringer Ingelheim is recalling specific bottles of Catapres tablets because routine stability testing revealed they failed to meet dissolution specifications.
- Product
- Catapres .2 (clonidine hydrochloride, USP) 0.2mg, 100-count bottles, Rx only, Dist. by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA. Made in Germany. NDC 0597-0007-01
- Category
- Drug
- Distribution
- Distributed nationwide